Specialty hospital uses Gloria Gaynor's I will Survive to create a PSA that calls on health care practitioners to deliver equitable care for those living with HIV
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) - Casey House – a hospital unlike any other providing care to those living with and at risk of HIV – today announces the launch of its latest advocacy campaign, Stigmavir. This initiative aims to reach health care practitioners and introduces a ‘fictitious' anti-viral drug named Stigmavir, designed to treat HIV stigma. Stigma in health care is harming people living with HIV, with one in five people living with HIV being denied. The campaign includes an upbeat musical public service announcement (PSA), set to a musical adaptation of the iconic song "I Will Survive” with rights provided by Gloria Gaynor herself.
“Even in spaces run by people educated about health, HIV stigma persists. The Stigmavir campaign marks the next chapter in our longstanding Smash Stigma initiative to eradicate HIV stigma,” says Joanne Simons, Casey House CEO. “Stigma remains a significant barrier for individuals living with HIV seeking access to health care. This year we're inviting other health care providers to join us in the mission to create positive health care spaces that are informed, sensitive, inclusive, and inquisitive rather than assumptive. Everyone deserves health care that meets their needs, treats them with respect and maintains confidentiality.”
For people living with HIV, stigma is one of the most reported barriers to accessing health care. Disclosure to medical professionals can result in stares, micro-aggressions, and even denial of care, particularly during vulnerable moments like emergency or mental health care. Experiences of prejudice, discrimination, and stigma can cause patients to internalize this negativity, leading to a higher risk of depression and worse health outcomes, such as a delayed diagnosis.
“Despite the scientific advancements in health care and increased knowledge of HIV, unfortunately stigma still exists,” says Dr. Eileen de Villa, Toronto's Medical Officer of Health who is recognizing the hospital's Stigmavir initiative for its innovative approach. “Health care leaders like Casey House play a crucial role in educating Canada's health care providers on what stigma-free care truly involves. Initiatives like Stigmavir not only raise awareness of overlooked issues but also empower health care providers with the essential tools and resources to offer compassionate care to their patients.”
Casey House is leading the charge against HIV stigma in health care by inviting health care practitioners to join the movement in creating compassionate spaces for those living with or at risk of HIV. While Stigmavir is fictitious, it is an invitation to think about the way everyone in health care engages with people living with HIV; to reconsider how small actions can impact the people receiving care. What does health care look like without HIV stigma? Patients can build a trusting relationship with a health care provider, look forward to consistent treatment, and feel safe as they pursue good health. Casey House has also created a campaign website that offers health care providers additional resources on delivering compassionate care to those living with or at risk of HIV.
“People still don't like having positive people around, and also it's hard that we're still facing stigma from health care practitioners,” says Yasir, a documentary participant involved in the project. “This message is important because it not only invites health care providers to provide compassionate care and recognize unconscious biases, but also shares stories from HIV+ individuals and their experiences of receiving equitable care.”
Additionally, Casey House has created an HIV Stigma-Free symbol, similar to LGBTQ+ signage seen in the windows of businesses, available for download by health care practitioners. This symbol, accompanied by a toolkit of resources, will signify their efforts to provide stigma-free care for individuals living with HIV.
Join us. Consider whether Stigmavir is right for you and help Casey House improve health care experiences for people living with HIV. Spread awareness by sharing on social media using #smashstigma and stigmavir.ca to learn more.
To access the video PSA and high-res photography, please visit: LINK
To book an interview with any of our following spokespeople or for more information about the Stigmavir campaign please contact:
Aaron Short
Aaron.short@narrative.ca
905-442-1923
Spokespeople available for interviews include:
- Joanne Simons, CEO of Casey House
- Dr. Ed Kucharski, Chief Medical Officer of Casey House
- Our HIV+ documentary participants
About Casey House:
Casey House is unlike any other hospital. We are a specialty hospital in Toronto providing ground-breaking care to people living with and at risk of HIV. Together with our clients, staff, peers and volunteers, we strive to create an inclusive environment where everyone feels safe. We offer a growing mix of inpatient, and outpatient services that meet clients where they are in their individual journeys of health and wellness and actively dismantle barriers to care and safe living. As a hospital that strives to create an inclusive environment where everyone feels safe, we're also tackling the deeply ingrained stigma associated with HIV. With bold ideas and brave partners, we make the humanity of each client the heart of everything we do.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3e816fa6-900a-4702-9b9b-148d22cf0848
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17